InSphero at the SLAS 2025
Join us at the SLAS 2025 in San Diego. This key event gathers professionals from the toxicology community to exchange insights, research, and innovations. We look forward to connecting with fellow attendees and engaging in valuable discussions.
Discover all our activities that will be taking place during the ACT Annual Meeting 2024 in Austin, Texas from Sunday, November 17 to Wednesday, November 20. See you there!
Meet our Team at the SLAS 2025


Jan Lichtenberg, PhD
Jan Lichtenberg, PhD
CEO and Co-Founder




Madhu Nag, PhD
Madhu Nag, PhD
Chief Scientific Officer




Frauke Greve, PhD
Frauke Greve, PhD
Senior Product Manager




Nils Goedecke, PhD
Nils Goedecke, PhD
Product Owner




Olivier Frey, PhD
Olivier Frey, PhD
Vice President, Technologies and Platforms


Our Booth at the SLAS 2025
Visit our booth #2623 and discover our Scalable, Reliable and Reproducible 3D In Vitro Technology designed to empower researchers and accelerate a new era of breakthrough therapies.
Posters at the SLAS 2025
Species-Specific Liver Microtissues: A Set of Microphysiological Systems to Assess Translational Hepatotoxicity in Drug Development
Date: Monday, 18 November, 2024 | 5:00 - 6:30 PM
Poster number: P405


Maria Vittoria Colombo, PhD
Maria Vittoria Colombo, PhD
Scientist / Product Coordinator


Solutions Spotlight Presentation at the SLAS 2025
In Vitro Hepatotoxicity Assessment with the 3D InSight™ Liver Microtissue Platform
Date: Monday, 27 January, 2025 | 12:30 - 12:5o PM
Location: Level 2, Room 204
Presentation of the 3D InSight™ Liver microtissue platform, a versatile, scalable, and industry-compatible in vitro system, and of its uses for predictive, investigative, and translational hepatotoxicity assessment applications.


Bruno Filippi, PhD
Bruno Filippi, PhD
Vice President, Liver Safety


